These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37775259)

  • 1. Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine.
    Mares V; Schmidt-Erfurth UM; Leingang O; Fuchs P; Nehemy MB; Bogunovic H; Barthelmes D; Reiter GS
    Br J Ophthalmol; 2024 Jun; 108(7):971-977. PubMed ID: 37775259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness!
    Reiter GS; Mares V; Leingang O; Fuchs P; Bogunovic H; Barthelmes D; Schmidt-Erfurth U
    Can J Ophthalmol; 2024 Oct; 59(5):350-357. PubMed ID: 37989493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 4. Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
    ; Maguire MG; Martin DF; Ying GS; Jaffe GJ; Daniel E; Grunwald JE; Toth CA; Ferris FL; Fine SL
    Ophthalmology; 2016 Aug; 123(8):1751-1761. PubMed ID: 27156698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.
    Saenz-de-Viteri M; Recalde S; Fernandez-Robredo P; López Gálvez MI; Arias Barquet L; Figueroa MS; García-Arumí J; García-Layana A;
    Acta Ophthalmol; 2021 Dec; 99(8):861-870. PubMed ID: 33720541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration.
    Gigon A; Iskandar A; Kasser S; Naso S; Zola M; Mantel I
    Eye (Lond); 2024 May; 38(7):1342-1348. PubMed ID: 38279038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VALIDATION OF AN AUTOMATED FLUID ALGORITHM ON REAL-WORLD DATA OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION OVER FIVE YEARS.
    Gerendas BS; Sadeghipour A; Michl M; Goldbach F; Mylonas G; Gruber A; Alten T; Leingang O; Sacu S; Bogunovic H; Schmidt-Erfurth U
    Retina; 2022 Sep; 42(9):1673-1682. PubMed ID: 35994584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.
    Klimscha S; Waldstein SM; Schlegl T; Bogunovic H; Sadeghipour A; Philip AM; Podkowinski D; Pablik E; Zhang L; Abramoff MD; Sonka M; Gerendas BS; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4039-4048. PubMed ID: 28813577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Outcome in Patients with Neovascular Age-Related Macular Degeneration Switched from Ranibizumab to 8-Weekly Aflibercept.
    Chatziralli I; Nicholson L; Vrizidou E; Koutsiouki C; Menon D; Sergentanis TN; Citu MC; Hamilton R; Patel PJ; Hykin P; Sivaprasad S
    Ophthalmology; 2016 Aug; 123(8):1762-1770. PubMed ID: 27289179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial.
    Bailey C; Scott LJ; Rogers CA; Reeves BC; Hamill B; Peto T; Chakravarthy U; Harding SP;
    Ophthalmology; 2019 Jan; 126(1):75-86. PubMed ID: 30301555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration.
    Schmidt-Erfurth U; Vogl WD; Jampol LM; Bogunović H
    Ophthalmology; 2020 Sep; 127(9):1211-1219. PubMed ID: 32327254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.
    Keenan TDL; Chakravarthy U; Loewenstein A; Chew EY; Schmidt-Erfurth U
    Am J Ophthalmol; 2021 Apr; 224():267-281. PubMed ID: 33359681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database.
    Martin-Pinardel R; Izquierdo-Serra J; De Zanet S; Parrado-Carrillo A; Garay-Aramburu G; Puzo M; Arruabarrena C; Sararols L; Abraldes M; Broc L; Escobar-Barranco JJ; Figueroa M; Zapata MA; Ruiz-Moreno JM; Moll-Udina A; Bernal-Morales C; Alforja S; Figueras-Roca M; Gómez-Baldó L; Ciller C; Apostolopoulos S; Mosinska A; Casaroli Marano RP; Zarranz-Ventura J;
    Br J Ophthalmol; 2024 Jan; 108(2):253-262. PubMed ID: 36627173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD).
    Liakopoulos S; Spital G; Brinkmann CK; Schick T; Ziemssen F; Voegeler J; Koch M; Kirchhof B; Holz FG; Pauleikhoff D; Schmitz-Valckenberg S
    Br J Ophthalmol; 2020 Nov; 104(11):1573-1578. PubMed ID: 32066561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.
    Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA
    Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural Outcome.
    Gianniou C; Dirani A; Jang L; Mantel I
    Retina; 2015 Jun; 35(6):1195-201. PubMed ID: 25650710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.